Skip to main content
. 2022 Nov 28;10(12):3056. doi: 10.3390/biomedicines10123056

Figure 1.

Figure 1

In vitro reduction of IL-1β secretion. (A) Porcine peripheral blood mononuclear cells (PBMCs) released IL-1β after administration of lipopolysaccharide (LPS) and adenosine triphosphate (ATP) in vitro. Addition of IZD334 reduced IL-1β release (n = 3). (B) Whole blood IC50 calculation after stimulation with LPS and ATP and administration of increasing concentrations of IZD334 in vitro. p-values (** <0.005, *** <0.0005) are compared to vehicle control (0 µM of IZD334).